Thyroid receptor: roles in cancer
Authors:
- Ana ArandaAAAna Aranda
- Olaia Martínez-IglesiasOMOlaia Martínez-Iglesias
- Lidia Ruiz-LlorenteLRLidia Ruiz-Llorente
- Verónica García-CarpizoVGVerónica García-Carpizo
- Alberto ZambranoAZAlberto Zambrano
- 1 September 2009
- journal article
- review article
- Published by Elsevier in Trends in Endocrinology & Metabolism
- Vol. 20 (7) , 318-324
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Nongenomic activation of phosphatidylinositol 3-kinase signaling by thyroid hormone receptorsSteroids, 2009
- Multi-modulation of nuclear receptor coactivators through posttranslational modificationsTrends in Endocrinology & Metabolism, 2009
- PTEN deficiency accelerates tumour progression in a mouse model of thyroid cancerOncogene, 2008
- Regulation of β-Catenin by a Novel Nongenomic Action of Thyroid Hormone β ReceptorMolecular and Cellular Biology, 2008
- Lung metastasis genes couple breast tumor size and metastatic spreadProceedings of the National Academy of Sciences, 2007
- Rapid nongenomic actions of thyroid hormoneProceedings of the National Academy of Sciences, 2006
- Thyroid Hormone Receptor α1 Directly Controls Transcription of the β-Catenin Gene in Intestinal Epithelial CellsMolecular and Cellular Biology, 2006
- Essential contribution of a chemokine, CCL3, and its receptor, CCR1, to hepatocellular carcinoma progressionInternational Journal of Cancer, 2005
- Principles for modulation of the nuclear receptor superfamilyNature Reviews Drug Discovery, 2004
- ON THE TREATMENT OF INOPERABLE CASES OF CARCINOMA OF THE MAMMA: SUGGESTIONS FOR A NEW METHOD OF TREATMENT, WITH ILLUSTRATIVE CASES.1The Lancet, 1896